
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for IPZYF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IPZYF and 80,000+ other tickers.
See exactly how IPZYF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IPZYF and 80,000+ other tickers.
IP Group Plc is an investment firm specializing in private equity and venture capital. It deploys capital across a spectrum of funding stages, including seed, early-stage, start-up, and incubation, as well as providing growth financing and support for more mature enterprises. A key focus is offering seed capital to companies originating from university spin-outs. The firm's investment scope is broad, encompassing sectors such as life sciences, physical sciences, energy & renewables, medical equipment and supplies, healthcare, technology, cleantech, intellectual property, pharmaceuticals &…

Railpen, the largest shareholder in Britain's IP Group , said on Monday that it does not intend to make another offer for the early-stage science investor as the companies could not agree on a mutually acceptable proposal.

Frontier IP Group PLC (LSE:FIPP, FRA:8WT) said its portfolio company Cambridge Raman Imaging has secured a €400,000 European grant as it targets pharmaceutical manufacturing quality control and prepares pilot testing with two industry groups. The non-dilutive European Innovation Council funding will support the scale-up of CRI's high-speed Raman imaging and artificial intelligence technology.

The board of IP Group PLC (LSE:IPO), the London-listed technology investor, may struggle to recommend an improved takeover proposal from pension fund Railpen without further concessions, according to Deutsche Bank. Railpen returned with a revised offer ahead of today's put up or shut up deadline, when it must either make a firm bid or walk away.

SANTA CLARA, Calif. & OXFORD, England--(BUSINESS WIRE)-- #Mach42--Mach42 completes £7m funding round, led by IP Group with investment from BGF and Foresight Group.

IP Group's board of directors on Monday unanimously rejected a sweetened 71.3 pence-per-share takeover proposal from its largest shareholder, Railpen, citing significant undervaluation of the company and its prospects.